News

27 April 2021

BAP Pharma Limited sign an exclusive agreement for the supply and distribution of Bicillin® LA (Penicillin G Benzathine pre-filled syringe) to treat patients with bacterial infections in the UK and Europe.

BAP Pharma Limited is pleased to announce the signing of an exclusive agreement for the supply and distribution of Bicillin® L-A (Penicillin G Benzathine) to expand access to the product in the UK and Europe (previously only available in the US)

 

Product Details

Bicillin® L-A is a ready-to-use Benzathine Benzylpenicillin, also known as Penicillin G Benzathine (PBG) slow-onset, long-acting antibiotic in prefilled syringes that fights bacteria in the body.

Bicillin® L-A belongs to the group of penicillin antibiotics and works by killing bacteria or preventing their growth. This particular type of Bicillin is called Bicillin® L-A because it is long-acting.

Bicillin® L-A is supplied as a prefilled syringe in a pack of ten, for single use only.

 

Product Usage

Bicillin® L-A is used to treat a wide variety of venereal bacterial infections in different parts of the body caused by bacteria, such as Syphilis, Yaws, Bejel and Pinta, as well as Rheumatic Fever and/or Chorea.

 

Product Approval

Bicillin® L-A (Penicillin G Benzathine) has received approval from the Food and Drug Administration (FDA)

 

For More Information

To obtain additional information regarding Bicillin® LA (Penicillin G Benzathine) Expanded Access Program, please contact our Medicines Access team at: [email protected] or call: 01753 980250.

 

BAP Pharma Limited

BAP Pharma are global leaders in clinical trial supply, specialising in Medicines Access, Comparator Sourcing and Secondary Packaging & Labelling.

We work with our clients to provide bespoke solutions to ensure patients can gain access to the treatment they require through commercial supply or on a named patient basis. Our extensive experience in the pharmaceutical industry and our global storage and distribution capabilities, allows us to fully understand customer supply needs and truly deliver on our promise.

 

‘Promise Delivered’

 

Our focus is on delivering a high-quality, well-informed service to customers, ensuring that we proactively manage the whole supply from start to finish, using quality partners. This ensures products are received in the perfect condition.

BAP Pharma’s added value assures clients that our dedicated team will provide innovative solutions. This allows compliant and uncomplicated access to their product and maximises the potential of their product at the Pre- and Post-Approval stage. This increases patient access to sought-after medicines that were previously unavailable.

The BAP Pharma group have headquarters in the UK, Germany & USA and partners with storage facilities across the world, which gives us a true global reach.

You Might Also Like

BAP Pharma ranked in FEBE Growth 100 List

BAP Pharma are honoured to receive an award from FEBE Growth 100 and to have been ranked within the 2022 list of the fastest growing, founder-led, privately-owned UK businesses. BAP Pharma receiving the FEBE Growth 100 Award – pictured left to right – Award Partner Anthony Higson from Pictet, FEBE

BAP Pharma ranked in FEBE Growth 100 List

BAP Pharma celebrates its 10th Anniversary

This month, BAP Pharma celebrated its 10th anniversary – marking 10 years since the company was first established in 2011. We came together as a company to celebrate this amazing milestone in style, with a wonderful James Bond themed, formal event at the Oakley Court Hotel, Windsor. After the lifting

BAP Pharma celebrates its 10th Anniversary

BAP Pharma Announces Grand Opening Ceremony for New US Headquarters in Somerset, NJ

BAP Pharma announced today that the Grand Opening Ceremony of its new US headquarters will be held on Wednesday, 24th of April 2024. SOMERSET, N.J.– (BUSINESS WIRE) – BAP Pharma will welcome guests and dignitaries to the Grand Opening Ceremony of its new headquarters on Randolph Road with a formal

BAP Pharma Announces Grand Opening Ceremony for New US Headquarters in Somerset, NJ